Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Shareholders Equity (Quarterly) : 265.78M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 265.78M |
| March 31, 2026 | 288.21M |
| December 31, 2025 | 306.83M |
| September 30, 2025 | 321.67M |
| June 30, 2025 | 336.43M |
| March 31, 2025 | 351.77M |
| Date | Value |
|---|---|
| December 31, 2024 | 166.66M |
| September 30, 2024 | 181.82M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 34.16M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.25B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Immunic, Inc. | 127.58M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 283.25M |
| Total Liabilities (Quarterly) | 17.47M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 20.05 |
| Net Debt Paydown Yield | 0.01% |